betahistine has been researched along with Dyslipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Lian, J; Liu, X; Su, Y | 1 |
| Deng, C; Hu, CH; Lian, J; Liu, X | 1 |
2 other study(ies) available for betahistine and Dyslipidemias
| Article | Year |
|---|---|
Epigenetic Histone Methylation of PPARγ and CPT1A Signaling Contributes to Betahistine Preventing Olanzapine-Induced Dyslipidemia.
Topics: Animals; Benzodiazepines; Betahistine; Carnitine O-Palmitoyltransferase; Dyslipidemias; Epigenesis, Genetic; Histones; Lysine; Methylation; Olanzapine; PPAR gamma; Rats | 2023 |
Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways.
Topics: AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Benzodiazepines; Betahistine; Dyslipidemias; Female; Liver; Olanzapine; PPAR alpha; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Sterol Regulatory Element Binding Protein 1; Weight Gain | 2015 |